| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Nasdaq expects the Regulatory Technology sub-division to grow within its medium-term revenue growth outlook range for full-year 2024. Nasdaq will provide additional details in the accompanying presentation and publicly announced conference call on this topic.
Beginning in the third quarter of 2024, Nasdaq's financial and operational results will reflect the new accounting treatment. In its third quarter 2024 results, Nasdaq will record a net $32 million one-time, non-cash GAAP revenue reduction for the period November 1, 2023 through June 30, 2024, reflecting the net impact of the accounting change on AxiomSL subscription revenue since the close of the acquisition. This $32 million net reduction consists of a decrease of $34 million related to the November and December 2023 periods, which will be excluded from our non-GAAP third quarter 2024 results, partially offset by a net increase of $2 million related to the January through June 2024 period.
Posted In: NDAQ
